Back

Hepatic T1-time predicts cardiovascular risk in all-comers referred for cardiovascular magnetic resonance.

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: CMR in the evaluation of cardiomyopathies and heart failure T1 and T2 Mapping ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Katharina Mascherbauer

Medical University of Vienna, Vienna (Austria)

7 More presentations in this session

Presentation thumbnail
Investigating myocardial energetic deficit across the spectrum of cardiac disease
Doctor A. Henry (St Helier, JE)
Abstract Slides
Presentation thumbnail
Prognostic implications of trabecular complexity measured by fractal analysis in left ventricular noncompaction
Miss A. Romero Valero (Elche, ES)
Abstract Slides
Presentation thumbnail
Unmasking systolic impairment in HFpEF by cardiovascular magnetic resonance derived hemodynamic force assessment: Insights from the HFpEF stress trial
Doctor S. Backhaus (Bad Nauheim, DE)
Abstract Slides
Presentation thumbnail
Ratio between left and right ventricular end-diastolic volumes and outcomes in patients with heart failure and preserved ejection fraction
Doctor A. Aimo (Pisa, IT)
Abstract Slides
Presentation thumbnail
A phase 2a trial investigating ninerafaxstat - a novel cardiac mitotrope for the treatment of diabetic cardiomyopathy (IMPROVE-DiCE)
Doctor M. Hundertmark (Bern, CH)
Abstract Slides

Access the full session

Session thumbnail
CMR in the evaluation of cardiomyopathies and heart failure

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Presentation
CMR for inflammation, oedema, and the pericardium
thumbnail
Congress Presentation
How to do parametric mapping
thumbnail
Congress Presentation
Cardiac magnetic resonance imaging in the work-up and management of cardiac amyloidosis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources